In CRC and CRC liver metastasis patients, the infiltration and IFN‐γ secretion of these TRM cells can be increased by antiangiogenic therapy, and infusing CD103+CD8+ TRM cells back into the body can achieve better antitumor effects.137. The gene discussed is IFNG; the disease is colorectal carcinoma.